Which Medication Needs a Do Not Shake Auxiliary Sticker?

Insulin suspensions, mRNA vaccines like Comirnaty (Pfizer’s COVID-19 vaccine), and protein-based biologic drugs are the most common medications that require a “do not shake” auxiliary label. These medications contain fragile molecules or formulations that can be damaged, denatured, or made inaccurate by vigorous shaking. The reasons differ by drug type, but the core principle is the same: shaking introduces mechanical stress that changes the medication in ways that reduce its effectiveness or safety.

Insulin Suspensions

Cloudy insulin formulations, particularly intermediate-acting insulin (NPH) and premixed insulin combinations, are the most widely recognized medications carrying “do not shake” instructions. These suspensions need to be mixed before injection, but the mixing method matters. You gently roll the vial between your palms and invert it (turn it upside down and back) 10 times each, for a total of 20 movements, until the liquid turns uniformly milky white.

Vigorous shaking creates air bubbles trapped in the suspension. When you draw up your dose with a syringe or pen, those bubbles displace liquid insulin, meaning you end up injecting less medication than intended. For someone managing blood sugar, even small dosing errors can cause glucose levels to swing unpredictably. Clear insulin formulations (like rapid-acting or long-acting analogs) don’t need mixing at all, but if a normally clear insulin appears cloudy, it should not be used.

mRNA Vaccines

The FDA-approved labeling for Comirnaty explicitly states “Do not shake” across its various formulations. The single-dose prefilled syringes carry a straightforward “do not shake” instruction, while multi-dose vials that require dilution should be mixed by gently inverting 10 times rather than shaking. This applies to formulations for both adults and children.

mRNA vaccines use lipid nanoparticles, tiny fat-based carriers that protect the fragile genetic material inside. Shaking can disrupt these nanoparticle structures, potentially reducing the vaccine’s ability to deliver its payload to your cells. Other vaccines with similar lipid-based or adjuvant systems may carry comparable warnings, so checking individual product labeling is essential.

Biologic Medications and Monoclonal Antibodies

Biologic drugs, especially monoclonal antibodies, are among the most shake-sensitive medications in clinical use. These are large, complex protein molecules used to treat cancers, autoimmune diseases, and other serious conditions. Examples include trastuzumab (used in breast cancer treatment), adalimumab (used for rheumatoid arthritis and Crohn’s disease), and many others in this drug class.

Research on trastuzumab demonstrates exactly what happens when these drugs are shaken. At low concentrations, shaking caused a twofold increase in average particle size, likely from protein molecules pairing together into dimers. This happens because shaking forces proteins against air-water boundaries inside the vial, exposing parts of the molecule that are normally folded inward. Once exposed, these regions stick to each other, forming clumps called aggregates.

Aggregation isn’t just a potency problem. Clumped proteins can trigger immune reactions in the body, ranging from mild injection site reactions to potentially life-threatening responses. The protein essentially becomes unrecognizable to the body in its clumped form, and the immune system may treat it as a foreign invader. This is why biologic medications consistently carry handling instructions that warn against shaking and recommend gentle swirling or inversion instead.

Why Shaking Damages Protein-Based Drugs

Proteins are three-dimensional molecules that depend on their precise folded shape to work. Think of it like origami: the function depends entirely on the structure. Shaking creates turbulence that forces proteins against the air-liquid boundary inside a vial, where the physics are hostile to protein stability. The protein’s water-avoiding core gets dragged toward the air interface, causing it to partially unfold.

Research on human growth hormone illustrates how dramatic this effect can be. Under shaking stress, the amount of intact growth hormone steadily dropped, with only half remaining after just three hours. The suspected mechanism was protein adsorption to the gas-liquid interface, which facilitated unfolding and breakdown. Once a protein unfolds, it doesn’t refold correctly. Instead, the damaged molecules clump together, precipitate out of solution, or simply lose their biological activity.

How This Differs From “Shake Well” Medications

It’s worth noting that many medications carry the opposite instruction. Oral suspensions like carbamazepine (an anti-seizure medication) require thorough shaking before each dose because the active drug settles to the bottom of the bottle. Without adequate shaking, early doses contain too little drug and later doses contain dangerously concentrated amounts. Pharmacy staff are encouraged to shake stock bottles well before dispensing smaller quantities, and the “shake well” auxiliary label goes on the patient’s bottle as a reminder.

The key distinction is the type of formulation. Simple chemical suspensions (particles of a solid drug dispersed in liquid) need shaking to redistribute the drug evenly. Protein-based and lipid-based formulations need gentle mixing because their active components are structurally fragile. When a medication requires mixing but not shaking, the label will typically specify the alternative: roll between your palms, gently swirl, or invert a set number of times.

Handling During Transport and Storage

The “do not shake” concern extends beyond the moment of use. United States Pharmacopeia guidelines for sterile compounding note that physical shaking during transport, including through hospital pneumatic tube systems, can compromise drug stability. Facilities shipping or transporting medications with stability concerns are required to include specific handling instructions on the exterior of the container.

This is particularly relevant for pharmacies and clinics that receive biologic medications or vaccines by mail or courier. A vial that was vigorously jostled during delivery may have already sustained damage before it’s ever opened. For patients who pick up biologic medications from a pharmacy and transport them home, avoiding rough handling is part of proper medication care, along with maintaining the correct temperature.